New research shows that eating this tasty snack daily can help protect against the leading cause of vision loss in older ...

Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...

Baseline angiographic lesion characteristics predictive of clinical responsePublished in peer-reviewed journal Ophthalmic Surgery, Lasers and ...

Obstructive sleep apnea is associated with higher rates of age-related macular degeneration development and progression.

AMD affects a small region of the retina — the light-sensing tissue at the back of the eye — called the macula, which is responsible for our detailed central vision. After about the age of 50 ...

Right now, the IND-enabling studies are made to test the safety, tolerability, vector biodistribution, transgene expression, ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...

Dry AMD causes diminished vision accompanied by loss of central retinal pigmented epithelium (RPE) cells in individuals aged 55 and older. There are no approved vision-improving treatments for dry ...

Avirmax Biopharma Inc. has begun IND-enabling studies of ABI-201, a gene therapy for dry age-related macular degeneration ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMDARTEMIS ...

A recent study by Overnight Glasses has highlighted certain dietary choices that may contribute to declining vision. The ...

Q4 2024 Earnings Call Transcript March 3, 2025 Ocular Therapeutix, Inc. misses on earnings expectations. Reported EPS is ...